Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BCAXBCAX
8 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BICARA THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.2M shares of BCAX (BICARA THERAPEUTICS INC), worth $34.5M as of 2026-Q2. The position was increased (+39.9% shares). BCAX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$34.5M

Current Shares

1.2M

Total Value Change

+$33.3M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+39.9%
$34.5M0.0%$29.69
38
2026-Q1
Increased
830,906
+2.4%
$16.5M0.0%$17.92
29
2025-Q4
Decreased
811,400
-2.4%
$13.7M0.0%$16.12
0
2025-Q3
Increased
831,208
+23.6%
$13.1M0.0%$13.87
34
2025-Q2
Increased
672,485
+36.8%
$6.2M0.0%$8.71
35
2025-Q1
Increased
491,652
+5.4%
$6.4M0.0%$13.40
29
2024-Q4
Increased
466,642
+859.4%
$8.1M0.0%$17.00
44
2024-Q3
New
48,639
-
$1.2M0.0%$25.44
35

Other major holders of BCAX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used